Cytomx Thera (CTMX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 34,185 | 49,041 | 47,604 | 38,052 | 40,576 |
| Marketable Securities | 109,441 | 109,046 | 32,282 | 62,571 | 77,012 |
| Receivables | 1,629 | 1,869 | 1,956 | 3,103 | 3,352 |
| TOTAL | $149,217 | $164,621 | $86,628 | $107,305 | $124,180 |
| Non-Current Assets | |||||
| PPE Net | 1,721 | 1,946 | 2,229 | 2,467 | 2,942 |
| Intangibles | 1,423 | 1,459 | 1,496 | 1,532 | 1,569 |
| Other Non-Current Assets | 5,893 | 7,031 | 8,144 | 9,229 | 10,290 |
| TOTAL | $9,037 | $10,436 | $11,869 | $13,228 | $14,801 |
| Total Assets | $158,254 | $175,057 | $98,497 | $120,533 | $138,981 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 646 | 227 | 276 | 1,088 | 1,422 |
| Accrued Expenses | 12,408 | 11,503 | 11,406 | 12,338 | 16,742 |
| TOTAL | $41,029 | $39,223 | $50,201 | $85,772 | $119,228 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 22,379 | 22,050 | 33,226 | 67,201 | 96,063 |
| Other Non-Current Liabilities | 4,299 | 5,683 | 7,033 | 8,355 | 9,649 |
| TOTAL | $9,836 | $15,924 | $23,247 | $35,217 | $43,205 |
| Total Liabilities | $50,865 | $55,147 | $73,448 | $120,989 | $162,433 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 169,435 | 164,913 | 80,621 | 80,100 | 78,259 |
| Common Shares | 2 | 2 | 1 | 1 | 1 |
| Retained earnings | -682,437 | -668,208 | -668,054 | -691,579 | -710,455 |
| Other shareholders' equity | 104 | 33 | -1 | 27 | 40 |
| TOTAL | $107,389 | $119,910 | $25,049 | $-456 | $-23,452 |
| Total Liabilities And Equity | $158,254 | $175,057 | $98,497 | $120,533 | $138,981 |